Pfizer Covid-19 jab ‘100% effective’ in younger teenagers, research suggests
The Pfizer Covid-19 jab is “100% effective and well tolerated” among children aged 12 to 15, a new study suggests. Pfizer said it now plans to seek approval for use of the vaccine in this age group from regulators around the world and hopes youngsters will start to receive the jab before the next school year. The pharmaceutical company said it plans to submit the data to the UK regulator – the Medicines and Healthcare products Regulatory Agency – within the next couple of months. Researchers examined the use of the Pfizer/BioNTech vaccine in a trial of 2,260 teenagers in the US.
Evening Standard - March 31, 2021View the full story here: https://www.standard.co.uk/news/uk/pfizer-inc-oxford-university-public-health-england-fda-b927283.html